Polygenic risk of Alzheimer's disease in the Faroe Islands
- PMID: 35384166
- DOI: 10.1111/ene.15351
Polygenic risk of Alzheimer's disease in the Faroe Islands
Abstract
Background and purpose: The Faroe Islands are a geographically isolated population in the North Atlantic with a similar prevalence of Alzheimer's disease (AD) and all-cause dementia as other European populations. However, the genetic risk underlying AD and other dementia susceptibility has yet to be elucidated.
Methods: Forty-nine single-nucleotide polymorphisms (SNPs) were genotyped in 174 patients with AD and other dementias and 159 healthy controls. Single variant and polygenic risk score (PRS) associations, with/without APOE variability, were assessed by logistic regression. Performance was examined using receiver operating characteristic area under the curve (ROC AUC) analysis.
Results: APOErs429358 was associated with AD in the Faroese cohort after correction for multiple testing (odds ratio [OR] 6.32, 95% confidence interval [CI] 3.98-10.05, p = 6.31e-15 ), with suggestive evidence for three other variants: NECTIN2 rs41289512 (OR 2.05, 95% CI 1.20-3.51, p = 0.01), HLA-DRB1 rs6931277 (OR 0.67, 95% CI 0.48-0.94, p = 0.02) and APOE rs7412 [ε2] (OR 0.28, 95% CI 0.11-0.73, p = 0.01). PRSs were associated with AD with or without the inclusion of APOE (PRS+APOE OR = 4.5, 95% CI 2.90-5.85, p = 4.56e-15 , and PRS-APOE OR = 1.53, 95% CI 1.21-1.98, p = 6.82e-4 ). AD ROC AUC analyses demonstrated a PRS+APOE AUC = 80.3% and PRS-APOE AUC = 63.4%. However, PRS+APOE was also significantly associated with all-cause dementia (OR = 3.39, 95% CI 2.51-4.71, p = 2.50e-14 ) with an AUC = 76.9%, that is, all-cause dementia showed similar results albeit less significant.
Discussion: In the Faroe Islands, SNP analyses highlighted APOE and immunogenomic variability in AD and dementia risk. PRS+APOE , based on 25 SNPs/loci, had excellent sensitivity and specificity for AD with an AUC of 80.3%. High PRSs were also associated with an earlier onset of late-onset AD.
Keywords: Alzheimer's disease; Faroe Islands; all-cause dementia; genetic risk; polygenic risk score.
© 2022 European Academy of Neurology.
Similar articles
-
Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.Transl Neurodegener. 2021 Aug 31;10(1):32. doi: 10.1186/s40035-021-00259-w. Transl Neurodegener. 2021. PMID: 34465370 Free PMC article.
-
Polygenic risk discriminates Lewy body dementia from Alzheimer's disease.Alzheimers Dement. 2025 Feb;21(2):e14381. doi: 10.1002/alz.14381. Epub 2025 Jan 24. Alzheimers Dement. 2025. PMID: 39853853 Free PMC article.
-
Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.Mol Psychiatry. 2021 Oct;26(10):5812-5822. doi: 10.1038/s41380-020-0764-y. Epub 2020 May 13. Mol Psychiatry. 2021. PMID: 32404947 Free PMC article.
-
From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.J Alzheimers Dis. 2020;74(4):1271-1283. doi: 10.3233/JAD-191233. J Alzheimers Dis. 2020. PMID: 32250305 Free PMC article.
-
The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk.Int J Mol Sci. 2019 Mar 7;20(5):1177. doi: 10.3390/ijms20051177. Int J Mol Sci. 2019. PMID: 30866553 Free PMC article. Review.
Cited by
-
MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus.J Neuroinflammation. 2022 Jul 12;19(1):180. doi: 10.1186/s12974-022-02548-1. J Neuroinflammation. 2022. PMID: 35821145 Free PMC article.
References
REFERENCES
-
- Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41(10):1094-1099.
-
- Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41:1088-1093.
-
- Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
-
- Marioni RE, Harris SE, Zhang Q, et al. GWAS on family history of Alzheimer's disease. Transl Psychiatry. 2018;8(1):99.
-
- Jansen IE, Savage JE, Watanabe K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51(3):404-413.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous